... test a prime-boost combination of two HIV vaccine candidates. The news follows promising results for one ... the two vaccine candidates to be tested, the MVA-based TBC-M4, which in a recent phase I trial ...
... used functional screening of cowpox to identify new vaccine candidates against similar viruses. These were compared with ... a cowpox challenge compared with the 4-pox vaccine. (See figure 1) The 4-pox ...
Interim Analysis of Clinical Phase I Data Triggered Decision to Move Alzheimer's Vaccine Candidate AD02 into Clinical Phase II Testing
... in 1999,” he said.
“A vaccine is desperately needed and while a number of vaccine candidates are currently in development, none have yet been approved for human use. Following this research we hope ...
... animals and 29 days in control animals.
"We think this identifies a novel class of vaccine candidate targets for tumors that originate and metastasize from mucosa, like colorectal cancer," Dr. ...
Failure to find an HIV vaccine candidate should not mean shutting down clinical trial centres in Africa, say researchers.
... saw in the clinical trial participants," Turley said. "UTMB is committed to further studies of the vaccine candidate, which has the potential to be a safe, highly effective and much-needed option to ...
... help determine whether a new vaccine is rallying an effective response. "We are now evaluating vaccine candidates and changing them so they not only induce antibodies, but also induce this specific ...
... different from the immune responses elicited by the Merck vaccine candidate in this trial," said Susan Buchbinder, M ... kill HIV-infected cells. Because the vaccine did not contain live HIV and contained ...
New findings show that a T cell-based strategy remains a viable course to follow in the development of an HIV-1 vaccine.
... Malaria & International Health at LSHTM, reports that a slightly different formulation of the vaccine candidate, which is being developed for delivery through the EPI, has a promising safety profile ...
As vaccines against a virus that infects 100 million people annually reach late-stage clinical ... a test to better predict whether a given vaccine candidate should protect patients from the infection, ...
... lives, but hopes for a true solution lie with vaccine design," said Xia Jin, M.D., ... dengue serotypes simultaneously and equally, and several vaccine candidates have generated unequal responses across ...
As vaccines against a virus that infects 100 million people annually reach late-stage clinical ... a test to better predict whether a given vaccine candidate should protect patients from the infection, ...
... natural immune system response that was the target of all previous HIV and SIV vaccine candidates," said study leader Philip R. Johnson, M.D., chief scientific officer at The Children ...
